Sumanta Kumar Pal, MD, City of HopeÂ
Advertisement
Articles by Sumanta Kumar Pal, MD, City of HopeÂ
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Belzutifan Plus Lenvatinib Raises New Sequencing Questions in Advanced RCC
2
EU, Japanese Approval Is Sought for Savolitinib Plus Osimertinib in MET-Driven EGFR-Mutated NSCLC
3
Dr Hansen on the Potential Role of GPRC5D-Targeted CAR T-Cell Therapy in Myeloma
4
Camizestrant Approval Paves the Way for ctDNA-Guided Switching in Emergent ESR1-Mutated HR+/HER2– Advanced Breast Cancer
5
